Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Lets hope so, ive been holding these for a fair few months now. It oscillates a fair bit, but the recent rise seems more sustainable.
The 4.5 year breakout is on, this could be explosive.
https://www.aortech.net/investor-relations/director-biographies/
Fascinating stuff: https://www.researchgate.net/figure/Top-view-of-the-23-mm-Aortech-polymeric-heart-valves-in-their-unstressed-state-a_fig1_6999603
https://csiropedia.csiro.au/elast-eon-biocompatible-polyurethane/
These are the excerpts from the recent broker note. Have to suspect this is now in advanced stages...
A £2.5m annual royalty would be valued at a PE ratio of 25-50 times I suspect. i.e. we'd be looking at a Market Cap of £62.5-125m just on the Breast IP ! (ARM was valued at 50-100x PE on its Royalty income)
"A leading device manufacturer is investigating using AorTech's technology for its next generation products.
Development plan
AorTech is in the early stages of an investigatory programme with a breast implant business that has identified the opportunity to develop new technology to drive its business in the future.
Opportunities for Aortech
This project requires little investment by AorTech but, if successful, would result in either a very attractive licence and royalty income or a JV opportunity to disrupt current technologies and supply chains. Not assumed in our projections, but as an indication of the potential value is that a 5% royalty on a 5% global market share would generate an income stream of £2.5m per annum to AorTech."
3 (THREE !) potential game-changers to AorTech tech/IP in the breast implant/reconstruction market
landy9 04 Jul '18 - 08:15 - 453 of 487
Breast implant tech has not really changed over the last 40 years. AORTECH has three potential game changers
1. SHELL
A more durable and abrasion resistant shell material, so improving safety and life of implant
2. FILLER
A gel compound that is much lower density than silicon gel, thus reducing the weight of the implant giving a more natural feel. They also have a foaming tech that would also reduce density of implant.
3. PROCEDURE
A process for filling an implant in situ, thus making the procedure minimally invasive with less scarring.
Can you post them on this bb ?
Some great posts over on ADVFN might work checking it out for those who only use this BB.
I think we should get a nice sustained news flow over the coming weeks/months. It really does look like a true rerate is on here. MCap is very low considering everything.
New breast implants for Brazil then
Lots of TA traders looking for that break on the verge think we clear it today then blue skies 100p first target for me GLA
Not many seen the RNS yet but NT to buy
Mcap a joke now, should be double easy
Another Patent -------------Boom!
The better it gets
this was priced to go pop at 2m market cap not long ago looking at the May stats
https://www.londonstockexchange.com/statistics/markets/aim/aim.htm
The lowest valued medical device company on AIM
I can't believe how much of a turn around story there is here to develop and unfold.
2 x new partnerships
1 x new patent
£60m on research & Development
Profitable
Self sufficient licenses pays over heads for operations
Licences are below market cap value (may rns)
lovely
Fully ask constantly to buy, can’t wait for this to really get started
Yes it definitely will do, personally adding small amounts as very difficult to buy in quantity as so few shares
This is likey to bag many times over, but I wonder when people will actually start taking notice of how unreal and low the current MCap is?
DYOR as always, but I fully expect the herd to arrive here at some point and when they do it will be explosive to say the least.
Just how we like it
Buyer at mid with plenty cash
I wonder what chance there is that there are some directors buys going through?....hmmm
Mms need supply big volume here and there in trouble
NT to buy here on several occasions this morning, large buys going through too.
Seller back off ready to go again imo
Good volume this morning seller put the brakes on for now, it breaks 60 we’re off to the races GLA
Good volume this morning seller put the brakes on for now, it breaks 60 we’re off to the races GLA